Category:
Prophylactic Biological Products
CAS NO:
1254053-43-4
Standard:
In-house Standards,
Gilteritinib fumarate
| Status | Pipeline |
| Development phase | Initial stage |
| Therapeutic cat. | Oncology |
| CAS No. | 1254053-43-4 |
| OEB No. |
4 |
Drug description
Gilteritinib is an AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia.
DISCLAIMER Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement.